nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—Ifosfamide—testicular cancer	0.113	0.47	CbGbCtD
Esomeprazole—CYP3A4—Ifosfamide—testicular cancer	0.0544	0.227	CbGbCtD
Esomeprazole—CYP3A4—Vinblastine—testicular cancer	0.0289	0.121	CbGbCtD
Esomeprazole—CYP3A4—Etoposide—testicular cancer	0.026	0.109	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—testicular cancer	0.0177	0.0741	CbGbCtD
Esomeprazole—Visual impairment—Methotrexate—testicular cancer	0.000429	0.000564	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000425	0.000559	CcSEcCtD
Esomeprazole—Vomiting—Ifosfamide—testicular cancer	0.000425	0.000559	CcSEcCtD
Esomeprazole—Hypersensitivity—Cisplatin—testicular cancer	0.000424	0.000558	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—testicular cancer	0.000424	0.000557	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—testicular cancer	0.000422	0.000555	CcSEcCtD
Esomeprazole—Rash—Ifosfamide—testicular cancer	0.000421	0.000554	CcSEcCtD
Esomeprazole—Dermatitis—Ifosfamide—testicular cancer	0.000421	0.000553	CcSEcCtD
Esomeprazole—Erythema multiforme—Methotrexate—testicular cancer	0.000421	0.000553	CcSEcCtD
Esomeprazole—Urticaria—Etoposide—testicular cancer	0.000419	0.000551	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—testicular cancer	0.000418	0.00055	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—testicular cancer	0.000418	0.00055	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—testicular cancer	0.000417	0.000549	CcSEcCtD
Esomeprazole—Abdominal pain—Etoposide—testicular cancer	0.000417	0.000548	CcSEcCtD
Esomeprazole—Body temperature increased—Etoposide—testicular cancer	0.000417	0.000548	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000417	0.000548	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—testicular cancer	0.000417	0.000548	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—testicular cancer	0.000416	0.000547	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—testicular cancer	0.000416	0.000547	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—testicular cancer	0.000415	0.000545	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000414	0.000545	CcSEcCtD
Esomeprazole—Asthenia—Cisplatin—testicular cancer	0.000413	0.000543	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—testicular cancer	0.000413	0.000543	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000411	0.000541	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—testicular cancer	0.00041	0.000539	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—testicular cancer	0.000409	0.000538	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000409	0.000538	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—testicular cancer	0.000408	0.000537	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000406	0.000534	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—testicular cancer	0.000405	0.000532	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—testicular cancer	0.000403	0.000529	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—testicular cancer	0.000402	0.000528	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—testicular cancer	0.000401	0.000528	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000401	0.000527	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—testicular cancer	0.0004	0.000527	CcSEcCtD
Esomeprazole—Chills—Methotrexate—testicular cancer	0.000399	0.000525	CcSEcCtD
Esomeprazole—Nausea—Ifosfamide—testicular cancer	0.000397	0.000522	CcSEcCtD
Esomeprazole—Diarrhoea—Cisplatin—testicular cancer	0.000394	0.000518	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—testicular cancer	0.000394	0.000518	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—testicular cancer	0.000393	0.000517	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—testicular cancer	0.000392	0.000516	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—testicular cancer	0.00039	0.000512	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—testicular cancer	0.000389	0.000512	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—testicular cancer	0.000389	0.000511	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—testicular cancer	0.000388	0.00051	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—testicular cancer	0.000387	0.000509	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—testicular cancer	0.000386	0.000508	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—testicular cancer	0.000386	0.000508	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—testicular cancer	0.000385	0.000506	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000383	0.000504	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—testicular cancer	0.000382	0.000503	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.00038	0.0005	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—testicular cancer	0.000379	0.000499	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—testicular cancer	0.000379	0.000499	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—testicular cancer	0.000379	0.000498	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000378	0.000498	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—testicular cancer	0.000378	0.000496	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—testicular cancer	0.000376	0.000494	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—testicular cancer	0.000375	0.000493	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—testicular cancer	0.000375	0.000493	CcSEcCtD
Esomeprazole—Chills—Epirubicin—testicular cancer	0.000374	0.000491	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—testicular cancer	0.000373	0.000491	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—testicular cancer	0.000371	0.000488	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—testicular cancer	0.000368	0.000484	CcSEcCtD
Esomeprazole—Vomiting—Cisplatin—testicular cancer	0.000366	0.000481	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—testicular cancer	0.000365	0.00048	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—testicular cancer	0.000365	0.00048	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000364	0.000479	CcSEcCtD
Esomeprazole—Rash—Cisplatin—testicular cancer	0.000363	0.000477	CcSEcCtD
Esomeprazole—Dermatitis—Cisplatin—testicular cancer	0.000363	0.000477	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—testicular cancer	0.000362	0.000477	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—testicular cancer	0.000361	0.000475	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—testicular cancer	0.00036	0.000473	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—testicular cancer	0.000359	0.000472	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—testicular cancer	0.000359	0.000472	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—testicular cancer	0.000358	0.000471	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—testicular cancer	0.000357	0.00047	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—testicular cancer	0.000357	0.00047	CcSEcCtD
Esomeprazole—Tension—Epirubicin—testicular cancer	0.000356	0.000468	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—testicular cancer	0.000355	0.000467	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—testicular cancer	0.000352	0.000463	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—testicular cancer	0.000351	0.000461	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—testicular cancer	0.000349	0.000459	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—testicular cancer	0.000349	0.000459	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—testicular cancer	0.000348	0.000458	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—testicular cancer	0.000348	0.000457	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—testicular cancer	0.000348	0.000457	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000347	0.000456	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—testicular cancer	0.000347	0.000456	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—testicular cancer	0.000346	0.000454	CcSEcCtD
Esomeprazole—Nausea—Cisplatin—testicular cancer	0.000342	0.00045	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—testicular cancer	0.000342	0.000449	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—testicular cancer	0.00034	0.000448	CcSEcCtD
Esomeprazole—Cough—Methotrexate—testicular cancer	0.000338	0.000444	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—testicular cancer	0.000337	0.000444	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000336	0.000442	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—testicular cancer	0.000335	0.000441	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—testicular cancer	0.000335	0.000441	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—testicular cancer	0.000335	0.00044	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—testicular cancer	0.000333	0.000438	CcSEcCtD
Esomeprazole—Rash—Etoposide—testicular cancer	0.000333	0.000437	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—testicular cancer	0.000332	0.000437	CcSEcCtD
Esomeprazole—Headache—Etoposide—testicular cancer	0.000331	0.000435	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—testicular cancer	0.00033	0.000434	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—testicular cancer	0.00033	0.000433	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—testicular cancer	0.00033	0.000433	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—testicular cancer	0.00033	0.000433	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—testicular cancer	0.000329	0.000433	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—testicular cancer	0.000328	0.000432	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000327	0.000431	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—testicular cancer	0.000327	0.00043	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—testicular cancer	0.000326	0.000428	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—testicular cancer	0.000326	0.000428	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—testicular cancer	0.000326	0.000428	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—testicular cancer	0.000324	0.000427	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—testicular cancer	0.000324	0.000426	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—testicular cancer	0.000322	0.000424	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—testicular cancer	0.00032	0.000421	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—testicular cancer	0.000319	0.000419	CcSEcCtD
Esomeprazole—Cough—Epirubicin—testicular cancer	0.000316	0.000416	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—testicular cancer	0.000316	0.000416	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—testicular cancer	0.000316	0.000416	CcSEcCtD
Esomeprazole—Infection—Methotrexate—testicular cancer	0.000314	0.000413	CcSEcCtD
Esomeprazole—Nausea—Etoposide—testicular cancer	0.000313	0.000412	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—testicular cancer	0.000313	0.000411	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000311	0.000409	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—testicular cancer	0.00031	0.000408	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—testicular cancer	0.00031	0.000408	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000309	0.000407	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—testicular cancer	0.000309	0.000406	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—testicular cancer	0.000309	0.000406	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—testicular cancer	0.000309	0.000406	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—testicular cancer	0.000308	0.000405	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—testicular cancer	0.000307	0.000404	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—testicular cancer	0.000307	0.000404	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000306	0.000403	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—testicular cancer	0.000306	0.000402	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—testicular cancer	0.000305	0.000401	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—testicular cancer	0.000302	0.000398	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—testicular cancer	0.000302	0.000397	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—testicular cancer	0.000301	0.000396	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—testicular cancer	0.000301	0.000396	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—testicular cancer	0.0003	0.000395	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—testicular cancer	0.000298	0.000392	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—testicular cancer	0.000296	0.00039	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—testicular cancer	0.000296	0.000389	CcSEcCtD
Esomeprazole—Infection—Epirubicin—testicular cancer	0.000294	0.000386	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—testicular cancer	0.000293	0.000385	CcSEcCtD
Esomeprazole—Shock—Epirubicin—testicular cancer	0.000291	0.000383	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—testicular cancer	0.00029	0.000381	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—testicular cancer	0.00029	0.000381	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—testicular cancer	0.000289	0.000381	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—testicular cancer	0.000289	0.00038	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000288	0.000379	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—testicular cancer	0.000287	0.000378	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—testicular cancer	0.000286	0.000376	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—testicular cancer	0.000286	0.000376	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—testicular cancer	0.000285	0.000375	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—testicular cancer	0.000285	0.000375	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—testicular cancer	0.000285	0.000375	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—testicular cancer	0.000284	0.000374	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—testicular cancer	0.000284	0.000373	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000283	0.000373	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—testicular cancer	0.000282	0.000371	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—testicular cancer	0.000282	0.000371	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—testicular cancer	0.000282	0.00037	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—testicular cancer	0.000281	0.000369	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—testicular cancer	0.000279	0.000367	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—testicular cancer	0.000278	0.000366	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—testicular cancer	0.000276	0.000363	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—testicular cancer	0.000275	0.000361	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—testicular cancer	0.000274	0.00036	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000273	0.000359	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—testicular cancer	0.000272	0.000358	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—testicular cancer	0.000272	0.000357	CcSEcCtD
Esomeprazole—Pain—Methotrexate—testicular cancer	0.00027	0.000355	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000269	0.000354	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—testicular cancer	0.000269	0.000354	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—testicular cancer	0.000268	0.000353	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000268	0.000352	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—testicular cancer	0.000267	0.000352	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—testicular cancer	0.000267	0.000351	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—testicular cancer	0.000266	0.00035	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—testicular cancer	0.000266	0.000349	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000265	0.000348	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—testicular cancer	0.000264	0.000347	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—testicular cancer	0.000263	0.000346	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—testicular cancer	0.000261	0.000343	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—testicular cancer	0.00026	0.000342	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—testicular cancer	0.00026	0.000342	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—testicular cancer	0.000258	0.00034	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—testicular cancer	0.000257	0.000338	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000255	0.000336	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—testicular cancer	0.000255	0.000335	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—testicular cancer	0.000253	0.000333	CcSEcCtD
Esomeprazole—Pain—Epirubicin—testicular cancer	0.000253	0.000333	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—testicular cancer	0.000251	0.00033	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—testicular cancer	0.00025	0.000329	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—testicular cancer	0.00025	0.000329	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000249	0.000328	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—testicular cancer	0.000247	0.000325	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—testicular cancer	0.000246	0.000323	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—testicular cancer	0.000244	0.000321	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—testicular cancer	0.000244	0.00032	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—testicular cancer	0.000243	0.00032	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000242	0.000318	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—testicular cancer	0.000241	0.000317	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—testicular cancer	0.000238	0.000313	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000236	0.000311	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—testicular cancer	0.000236	0.00031	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—testicular cancer	0.000235	0.000309	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—testicular cancer	0.000234	0.000308	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—testicular cancer	0.000234	0.000308	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—testicular cancer	0.000234	0.000307	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—testicular cancer	0.000234	0.000307	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—testicular cancer	0.000233	0.000306	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—testicular cancer	0.000227	0.000298	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—testicular cancer	0.000225	0.000297	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000224	0.000294	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—testicular cancer	0.000224	0.000294	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—testicular cancer	0.000218	0.000287	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—testicular cancer	0.000217	0.000286	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—testicular cancer	0.000216	0.000284	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—testicular cancer	0.000216	0.000284	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—testicular cancer	0.000216	0.000284	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—testicular cancer	0.000212	0.000279	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—testicular cancer	0.000209	0.000275	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—testicular cancer	0.000209	0.000275	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—testicular cancer	0.000202	0.000266	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—testicular cancer	0.000202	0.000265	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—testicular cancer	0.000201	0.000264	CcSEcCtD
Esomeprazole—Rash—Methotrexate—testicular cancer	0.000199	0.000262	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—testicular cancer	0.000199	0.000262	CcSEcCtD
Esomeprazole—Headache—Methotrexate—testicular cancer	0.000198	0.00026	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—testicular cancer	0.000196	0.000258	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—testicular cancer	0.000196	0.000257	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—testicular cancer	0.000194	0.000255	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—testicular cancer	0.000188	0.000247	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—testicular cancer	0.000188	0.000247	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—testicular cancer	0.000187	0.000246	CcSEcCtD
Esomeprazole—Rash—Epirubicin—testicular cancer	0.000186	0.000245	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—testicular cancer	0.000186	0.000245	CcSEcCtD
Esomeprazole—Headache—Epirubicin—testicular cancer	0.000185	0.000244	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—testicular cancer	0.000181	0.000238	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—testicular cancer	0.000176	0.000231	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—testicular cancer	0.000174	0.000229	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—testicular cancer	0.000173	0.000227	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—testicular cancer	0.000172	0.000227	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—testicular cancer	0.000171	0.000225	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—testicular cancer	0.000163	0.000214	CcSEcCtD
